Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: RIPTIDE THERAPEUTICS LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-25 to 2024-09-24
Current total value of award: $400000
Description: SBIR TOPIC #446 PHASE I -DEVELOPMENT OF SENOTHERAPEUTIC AGENTS FOR CANCER TREATMENT